期刊文献+

冠状动脉溶栓在ST段抬高型心肌梗死中的研究进展

Coronary Thrombolysis in ST-Segment Elevation Myocardial Infarction
下载PDF
导出
摘要 ST段抬高型心肌梗死是常见的心血管急危重症,致死率和致残率高。尽早实现心肌再灌注可有效挽救濒死心肌,改善ST段抬高型心肌梗死患者的预后,冠状动脉内溶栓在实现再灌注过程中发挥重要作用。现从血栓形成的机制、溶栓剂分类、冠状动脉内正向溶栓、血栓抽吸、血栓抽吸联合冠状动脉内溶栓、冠状动脉内逆向溶栓及应用前景等方面展开综述。 ST-segment elevation myocardial infarction is a common emergent and critical cardiovascular disease with high mortality and disability rate.Early myocardial reperfusion can effectively save the dying myocardium and improve the prognosis of patients with ST-segment elevation myocardial infarction.Intracoronary thrombolysis plays an important role in the process of reperfusion.This article reviews the mechanisms of thrombogenesis,the classification of thrombolytic agents,intracoronary forward thrombolysis,thrombus aspiration,thrombus aspiration combined with intracoronary thrombolysis,intracoronary retrograde thrombolysis and its application prospect.
作者 周星儿 赵施皓 郭宇婷 金荣杰 王继航 王建 郭毅 田进文 沈明志 ZHOU Xing’er;ZHAO Shihao;GUO Yuting;JIN Rongjie;WANG Jihang;WANG Jian;GUO Yi;TIAN Jinwen;SHEN Mingzhi(The Second School of Clinical Medicine,Sourthen Medical University,Guangzhou 510000,Guangdong,China;Department of Cardiology,Hainan Hospital of PLA General Hospital,Sanya 572013,Hainan,China)
出处 《心血管病学进展》 CAS 2022年第3期229-231,240,共4页 Advances in Cardiovascular Diseases
基金 海南省重点研发计划(ZDYF2020123,ZDYF2019188,ZDYF2017096)。
关键词 ST段抬高型心肌梗死 心肌再灌注 溶栓剂 冠状动脉内溶栓 ST-segment elevation myocardial infarction Myocardial reperfusion Thrombolytic agents Intracoronary thrombolysis
  • 相关文献

参考文献8

二级参考文献51

  • 1李家增.血栓形成机制[J].临床内科杂志,2004,21(12):793-795. 被引量:31
  • 2宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 3任乐民,张云升,孟雅娟.溶栓药物的研究进展[J].实用中西医结合临床,2006,6(3):91-92. 被引量:7
  • 4金慧铭.病理生理学[M].北京:人民教育出版社,2004:3-5.
  • 5Du X,Gu M,Weisel JW,et al.Long range propagation of conformational changes in integrin alpha Ⅱb beta 3[J].J Biol Chem,1993,268(31):2308-2392.
  • 6Semeraro N,Biondi A,Lorenzet R,et al.Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anayomical sites[J].Immunology,1983,50(5):529-535.
  • 7Bevilacqua MP,Pober JS,Majeau GR,et al.Interleukin 1(IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells[J].J Exp Med,1984,160(5):608-623.
  • 8Ignerro LJ,Buga GM,Wood KS,et al.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide[J].Proc Natl Acad Sci USA,1987,84(24):9265-9269.
  • 9Palmer RM,Ferrige AG,Moncada S.Nitrric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(5):524-526.
  • 10Marcus AJ,Broekman MJ,Pinsky DJ.COX inhibitors and thromboregulation[J].N Engl J Med,2002,347(9):1025-1026.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部